Literature DB >> 10910256

Mechanisms of nephrotoxicity.

J M Campistol, S H Sacks.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10910256     DOI: 10.1097/00007890-200006271-00002

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


× No keyword cloud information.
  9 in total

1.  Characteristics of successful recruitment in prospective pediatric pharmacogenetic studies.

Authors:  Shannon N Saldaña; David K Hooper; Tanya E Froehlich; Kathleen M Campbell; Cynthia A Prows; Senthilkumar Sadhasivam; Todd G Nick; Michael Seid; Alexander A Vinks; Tracy A Glauser
Journal:  Clin Ther       Date:  2011-12-02       Impact factor: 3.393

2.  Evaluating the effect of sulphated polysaccharides on cyclosporine a induced oxidative renal injury.

Authors:  Anthony Josephine; Coothan Kandaswamy Veena; Ganapathy Amudha; Sreenivasan P Preetha; Palaninathan Varalakshmi
Journal:  Mol Cell Biochem       Date:  2006-05-16       Impact factor: 3.396

3.  Sustained renal response to mycophenolate mofetil and CNI taper promotes survival in liver transplant patients with CNI-related renal dysfunction.

Authors:  A Kornberg; B Küpper; K Thrum; B Krause; P Büchler; J Kornberg; A Sappler; A Altendorf-Hofmann; J Wilberg; H Friess
Journal:  Dig Dis Sci       Date:  2010-09-08       Impact factor: 3.199

4.  c-Jun-N-Terminal Kinase Signaling Is Involved in Cyclosporine-Induced Epithelial Phenotypic Changes.

Authors:  Nicolas Pallet; Eric Thervet; Dany Anglicheau
Journal:  J Transplant       Date:  2011-10-18

5.  Calcineurin-inhibitor minimization in liver transplant patients with calcineurin-inhibitor-related renal dysfunction: a meta-analysis.

Authors:  Yuan Kong; Dongping Wang; Yushu Shang; Wenhua Liang; Xiaoting Ling; Zhiyong Guo; Xiaoshun He
Journal:  PLoS One       Date:  2011-09-09       Impact factor: 3.240

6.  Cyclosporine A alters expression of renal microRNAs: New insights into calcineurin inhibitor nephrotoxicity.

Authors:  Jennifer L Gooch; Clayton King; Cynthia E Francis; Paul S Garcia; Yun Bai
Journal:  PLoS One       Date:  2017-04-17       Impact factor: 3.240

7.  Impact of immunosuppressive therapy on arterial stiffness in kidney transplantation: are all treatments the same?

Authors:  Edoardo Melilli; Anna Manonelles; Nuria Montero; Josep Grinyo; Alberto Martinez-Castelao; Oriol Bestard; Josep Cruzado
Journal:  Clin Kidney J       Date:  2017-11-23

8.  Influence of Belatacept- vs. CNI-Based Immunosuppression on Vascular Stiffness and Body Composition.

Authors:  Zbigniew Heleniak; Sarah Illersperger; Marcel G Naik; Bilgin Osmanodja; Simon Ronicke; Georgios Eleftheriadis; Fabian Halleck; Klemens Budde
Journal:  J Clin Med       Date:  2022-02-24       Impact factor: 4.241

9.  Induction of PPAR gamma mRNA and protein expression by rosiglitazone in chronic cyclosporine nephropathy in the rat.

Authors:  Kyung Ohk Ahn; Sun Woo Lim; Hyun Joo Yang; Can Li; Akira Sugawara; Sadayoshi Ito; Bum Soon Choi; Yong Soo Kim; Jin Kim; Chul Woo Yang
Journal:  Yonsei Med J       Date:  2007-04-30       Impact factor: 2.759

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.